Prothrombin activating protein
CA 2480904 A1 · Owner: The University Of Queensland · Inventors: De Jersey, John; Lavin, Martin; Masci, Paul Pantaleone
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The invention relates to snake venom protease polypeptides and nucleic acid sequences encoding same. This invention also relates to methods of making and using the snake venom proteases, e.g. to promote haemostasis and prevent blood loss such as during surgery or for treatment of wounds resulting from accidents and other types of injury or trauma.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed April 3, 2003. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended April 3, 2023.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by April 3, 2025.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.